BRAF and melanoma: A meta-analysis including 674 melanoma patients showed an increased risk of mortality in patients with BRAF-mutated melanoma (HR, 2.25; 95% CI, 1.37–2.12) compared with patients with wild-type BRAF melanoma [34].